According to research presented by ScienceDaily, people taking popular GLP-1 weight-loss medications like Ozempic and Wegovy are shedding pounds but moving less. A study analyzing Fitbit data found that daily step counts and exercise levels declined after patients started these drugs. The concern: because GLP-1s reduce muscle mass alongside fat, the resulting sedentary lifestyle could undermine strength and long-term health outcomes.

Listen to this story

Hear this and more stories in a personalized audio briefing.

Open The Chonkerton